Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1995
12/05/1995US5472841 Methods for identifying nucleic acid ligands of human neutrophil elastase
12/05/1995US5472693 Monoclonal antibodies
12/05/1995US5472692 Causes less fibrinogenolysis than native pro-urokinase; thrombolytic agents
12/05/1995US5472691 Superoxide dismutase
12/05/1995CA2047903C Calcitonin-containing emulsion for nasal administration
12/05/1995CA1337688C Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
12/02/1995CA2150612A1 Process for producing albumin preparation
11/1995
11/30/1995WO1995032430A2 Assay for pathogenicity of anti-dna antibodies
11/30/1995WO1995032425A1 Encoded combinatorial libraries
11/30/1995WO1995032310A1 Identification and use of antiviral compounds
11/30/1995WO1995032309A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032300A1 Selective biological destruction of tumor cells
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032291A2 Hepatitis g virus and molecular cloning thereof
11/30/1995WO1995032290A2 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
11/30/1995WO1995032287A1 Inducible defensin peptide from mammalian epithelia
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032283A1 Sequence-specific endonucleases, and preparation and use of same
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032280A1 Dna encoding human leukotriene c4 synthase, polypeptides, and uses therefor
11/30/1995WO1995032221A2 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
11/30/1995WO1995032219A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032216A1 Biologically active glycoprotein hormones produced in procaryotic cells
11/30/1995WO1995032213A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995WO1995032191A1 Inhibitors of farnesyl-protein transferase
11/30/1995WO1995032173A1 Compound bearing two 2,6-diiodophenol-4-yl groups and diagnostic drug for iodine allergy
11/30/1995WO1995032000A1 Hiv polyprotein immunogens
11/30/1995WO1995031996A1 Materials and methods for treatment of plaquing diseases
11/30/1995WO1995031995A1 Mimetics of senescent cell derived inhibitors of dna synthesis
11/30/1995WO1995031994A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995031981A2 Methods and compositions for reducing multidrug resistance
11/30/1995WO1995031904A1 Methods for the identification of hiv anti-viral agents capable of abrogating integrase interactor protein binding
11/30/1995WO1995031902A1 Predicting fetal membrane rupture by mmp-9 activity
11/30/1995WO1995031901A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/30/1995WO1995030002A3 Enhancing the sensitivity of tumor cells to therapies
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995WO1995027046A3 Enzymatic antimicrobial compositions containing haloperoxidases
11/30/1995DE4418635A1 Compsns. for treating excessive blood clotting
11/30/1995DE19518733A1 Pad for transdermal insulin delivery
11/30/1995CA2191202A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995CA2191191A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995CA2190860A1 Hepatitis g virus and molecular cloning thereof
11/30/1995CA2190846A1 Inhibitors of farnesyl-protein transferase
11/30/1995CA2190636A1 Methods and compositions for reducing multidrug resistance
11/30/1995CA2190613A1 Methods for the identification of compounds capable of abrogating hiv-1 vpr-rip-1 binding interactions
11/30/1995CA2190587A1 Identification and use of antiviral compounds
11/30/1995CA2190581A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/29/1995EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/29/1995EP0684259A1 L-lysyl-glycyl-L-histidine and therapeutic agent for wound healing containing the same
11/29/1995EP0684258A2 Tripeptide antithrombotic agents
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/29/1995EP0683817A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof
11/29/1995EP0683793A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
11/29/1995EP0683792A1 Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
11/29/1995EP0683791A1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof
11/29/1995EP0683675A1 Human monoclonal antibodies to cytomegalovirus
11/29/1995EP0683674A1 Use of thrombine inhibitors for controlling neurodegenerative diseases
11/29/1995EP0683660A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995EP0540560B1 Ancrod-like proteins, their preparation and their use
11/29/1995EP0535059B1 Dna sequence for a serine protease and associated items
11/29/1995EP0495047B1 Stable hemoglobin based composition and method to store same
11/29/1995EP0460076B1 Genetically engineered immunoglobulins
11/29/1995EP0440689B1 Anti-idiotypic antibody induction of antitumor response
11/29/1995EP0412116B1 Detection of neu gene expression and products
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/29/1995CN1112444A Treatment of infertility and enhancement of fertilization capacity in mammalian males
11/29/1995CN1112443A Oral peptide capable of promoting nerve growth and its preparing method
11/28/1995US5470970 Maspin, a serpin with tumor suppresing activity
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470960 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
11/28/1995US5470957 Monoclonal antibodies, anticoagulants
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470951 Alzheimer's
11/28/1995US5470950 Biologically active amphiphilic peptide compositions and uses therefor
11/28/1995US5470949 Method for making amino acid glycosides and glycopeptides
11/28/1995US5470948 Vasopressin and vasotocin derivatives
11/28/1995US5470947 CHRH antagonists with low histamine release
11/28/1995US5470911 Biocompatibility
11/28/1995US5470849 Anticoagulants
11/28/1995US5470839 Enteral diet and method for providing nutrition to a diabetic
11/28/1995US5470835 Transfer factor and methods of use
11/28/1995US5470834 Metalloproteinase enzyme inhibitors for arthritis, rheumatism and cancers
11/28/1995US5470833 Vasodilators, bronchodilators
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470831 Angiogenic peptides
11/28/1995US5470830 Motilin-like polypeptides that inhibit gastrointestinal motor activity
11/28/1995US5470829 Slow release of a growth factor or hormone
11/28/1995US5470828 Somatomedins, end group modification, growth regulators
11/28/1995US5470827 Method of producing iturin A and antifungal agent for profound mycosis
1 ... 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 ... 3163